Diuretic Comparison Project

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 20723 participants.

Also called NCT02185417

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 20,723 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02185417
Main results
  • Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events The New England journal of medicine, 2022-12-29 DOI, PubMed 36516076
Other papers using this trial's data
  • A Centralized EHR-Based Model for the Recruitment of Rural and Lower Socioeconomic Participants in Pragmatic Trials: A Secondary Analysis of the Diuretic Comparison Project JAMA network open, 2023-09-05 DOI, PubMed 37656456, PMC10474559 In the PMC Open Access subset under CC BY.
  • Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial JAMA network open, 2024-12-02 DOI, PubMed 39656458, PMC11632543 In the PMC Open Access subset under CC BY.
  • Chlorthalidone vs Hydrochlorothiazide for Hypertension Treatment After Myocardial Infarction or Stroke: A Secondary Analysis of a Randomized Clinical Trial JAMA network open, 2024-05-01 DOI, PubMed 38743423, PMC11094558 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Puerto Rico (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02185417. Randomized; no masking; primary purpose treatment. Start 2016-06-15 (actual); primary completion 2022-10-15 (actual). Results posted on 2024-05-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Diuretic Comparison Project
Acronym
DCP
Condition
Hypertension
Intervention (Drug)
Hydrochlorothiazide (HCTZ)
Intervention (Drug)
Chlorthalidone (CTD)
Lead sponsor
VA Office of Research and Development (class: US federal agency)

Record details

Record id
cardio:ct-nct02185417
Content hash
ac9ac861bf67c2fef64c1dadf0abe811c31052e8e98d5709d9e53b501cd5da9c